Implementation Science Grant Program

Johnson & Johnson Innovative Medicine is offering a Request for Proposals focused on implementation science initiatives within hematology, specifically targeting improvements in care for patients with relapsed or refractory multiple myeloma who may be eligible for bispecific antibody therapies. As part of its broader commitment to advancing equitable healthcare and supporting independent medical education, the organization funds projects that integrate education with real-world clinical practice improvements. These grants are distinct from traditional research funding in that they emphasize applying existing evidence-based practices rather than generating new scientific knowledge. The primary purpose of this funding opportunity is to support community-based healthcare organizations in implementing system-level or practice-level changes that improve patient outcomes. The initiative prioritizes proposals that embed certified continuing medical education within broader operational strategies, ensuring that learning activities directly influence clinical workflows, provider behavior, and care delivery processes. Projects must demonstrate how educational components are integrated with implementation strategies to address barriers to optimal care, particularly in community oncology settings. Funding is available for projects that enhance the adoption, integration, and sustainability of bispecific antibody therapies. Allowable uses include developing decision-support tools, establishing clinical protocols, training multidisciplinary care teams, improving patient education, and enhancing care coordination. However, funding cannot be used for institutional overhead, salaries, or durable medical equipment. Projects should focus on measurable improvements such as clinician behavior changes, workflow adoption, patient access, and overall care quality. All funded initiatives are expected to disseminate findings through professional channels such as publications or presentations. Eligibility is broad and includes community cancer centers, healthcare institutions, academic institutions, teaching hospitals, medical societies, government agencies, and medical education companies. Applications must be submitted through an accredited continuing medical education organization, and projects must offer certified CME or CE credits. Individual clinicians are encouraged to collaborate with their institution’s CME office or partner with an accredited organization if internal resources are unavailable. Research-focused proposals are explicitly excluded from consideration. The application process requires submission through the Johnson & Johnson Cybergrants portal. Applicants must indicate that their submission responds to this specific RFP and include the designated RFP title in their proposal. Required components include a detailed project design, assessment of need supported by data, clearly defined goals and objectives, identification of the target audience, an evaluation methodology, a project timeline, and a comprehensive budget. Proposals must also describe how the project will sustain outcomes beyond the grant period. Applications are due by June 30, 2026. Projects are expected to begin on or after September 1, 2026 and may run for up to 18 months. Applicants will be notified of funding decisions following a formal review process, typically within approximately 90 days of submission. During the project period, grantees must provide quarterly updates and submit a final report detailing educational reach, outcomes, clinical practice changes, system-level improvements, and sustainability strategies. The evaluation process emphasizes alignment with implementation science principles, integration of education with clinical operations, and the ability to achieve measurable outcomes. Proposals are reviewed by a grant committee, and additional information may be requested during evaluation. For inquiries, applicants may contact the program via email, and technical assistance for submission is available through the grant portal support system. This initiative reflects a structured and outcome-driven approach to advancing clinical practice through education and implementation.

Prioritize integration of education with operational change; clearly define measurable outcomes; demonstrate sustainability beyond grant period; align proposal with implementation science principles